Search Videos and More
News
GASTROINTESTINAL CANCER PROGRAM
Comprehensive Care That Empowers Patients Through Risk Management, Prevention, Detection, Treatment, and Survivorship Services
News
MELANOMA AND SKIN CANCER PROGRAM
Comprehensive Care Empowers Patients Through Risk Assessment, Prevention, Detection, Treatment, and Survivorship
News
BREAST CANCER PROGRAM
Comprehensive Care That Empowers Patients Through Risk Management, Prevention, Detection, Treatment, and Survivorship Services
Course
Thoracic Malignancies: A Review of the Latest Evidence
Great therapeutic strides have been made for non-small cell lung cancer (NSCLC). In this CME, renowned specialists from multidisciplinary backgrounds will present innovative treatment modalities that include medical, surgical and radiation oncology, pulmonology, and radiologic options. The conference explores new care paradigms for early-stage disease, including the CheckMate-816 trial that combines immunotherapy with chemotherapy, and a discussion of eligibility through molecular and PD-L1 testing. Targeted therapies for EGFR mutations or ALK translocations, and EGFR-targeted therapy for locally advanced disease will also be discussed.
Course
Thoracic Malignancies: A Review of the Latest Evidence
Great therapeutic strides have been made for non-small cell lung cancer (NSCLC). In this CME, renowned specialists from multidisciplinary backgrounds will present innovative treatment modalities that include medical, surgical and radiation oncology, pulmonology, and radiologic options. The conference explores new care paradigms for early-stage disease, including the CheckMate-816 trial that combines immunotherapy with chemotherapy, and a discussion of eligibility through molecular and PD-L1 testing. Targeted therapies for EGFR mutations or ALK translocations, and EGFR-targeted therapy for locally advanced disease will also be discussed.
News
National and International Accolades
Meet the bold clinicians and researchers whose work and perseverance push the edge of discovery, and have helped Fox Chase Cancer Center reach our 50th anniversary of excellence in cancer care.
News
Fox Chase Cancer Center Appoints Dr. Jeffrey M. Farma Chair of Surgery
Fox Chase Cancer Center has appointed Jeffrey M. Farma, MD, FACS, to Chair of Surgery following a succession of leadership roles at the center.
News
Fox Chase Cancer Center Opens First New Jersey Location in Voorhees
Fox Chase Cancer Center is proud to welcome patients to its newly opened office, which is located at 502 Centennial Boulevard, Suite 7, in Voorhees, New Jersey.
News
Fox Chase Researcher and Former Chief Fellow Presents Findings on 5-Aminolevulinic Acid-Mediated Radiation Therapy to Reduce Tumor Size
“Radiodynamic therapy is a combined treatment technique of photodynamic therapy and radiation therapy that treats cancer using light and radiation,” said Dae-Myoung Yang, PhD, an Assistant Professor in the Department of Radiation Oncology at Fox Chase.
News
A Prolific Career. An Auspicious Beginning.
As a genitourinary medical oncologist at Johns Hopkins, Jean Hoffman-Censits, MD, Associate Professor of Oncology and Urology, focuses on urothelial cancers of the bladder and upper tract, particularly women’s bladder cancer, which is often more aggressive than in men.
News
Fox Chase Vision Illuminated by Real Nurses and Real Patients
When asked to present the keynote at this year’s ONA Summit, Real Nurses, Real Solutions: Breakthrough Strategies in Oncology Nursing Practice, Anna Liza Rodriguez, MSN, MHA, RN, OCN, NEA-BC, Chief Nursing Officer and Vice President, Nursing and Patient Care Services at Fox Chase Cancer Center, had the Fox Chase nursing staff, support staff, and patients bring the theme to life in a heartfelt video, demonstrating Fox Chase's vision and values.
News
Temple University Hospital and Fox Chase Cancer Center Researchers Characterize HER2 Mutations in Patients With Lung Adenocarcinoma
Human epidermal growth factor 2 (HER2) mutations can be identified in up to 6% of non-small cell lung cancer cases where KRAS, EGFR, or ALK gene mutations are also found, according to the results of research from Temple University Hospital and Fox Chase Cancer Center presented today at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.